Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome? (Ultrasound in Obstetrics and Gynecology (2009) 33, (583-591) DOI: 10.1002/uog.6373);Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome?

Ultrasound in Obstetrics and Gynecology

Volumn 33, Issue 5, 2009, Pages 583-591

  Jayaprakasan, K ^a   Jayaprakasan, R ^a   Al Hasie, H A ^a   Clewes, J S ^a   Campbell, B K ^a   Johnson, I R ^a   Raine Fenning, N J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antral follicle count; In vitro fertilization; Ovarian blood flow; Ovarian hyperstimulation syndrome (OHSS); Three dimensional power Doppler ultrasound

Indexed keywords

FOLLITROPIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOGRAPHY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; MENSTRUAL CYCLE; MULTIPLE REGRESSION; OVARY; OVARY BLOOD FLOW; OVARY FOLLICLE; OVARY HYPERSTIMULATION; POWER DOPPLER ANGIOGRAPHY; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; TRANSVAGINAL ECHOGRAPHY; VASCULARIZATION;

EID: 66249111125     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7447     Document Type: Erratum

References (40)

1. Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril 2005; 84: 555-569.
2. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12: 685-718.
3. Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod 1991; 6: 1395-1399.
4. Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum Reprod 1992; 7: 320-327.
5. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002; 8: 559-577.
6. Mathur R, Kailasam C, Jenkins J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb) 2007; 10: 75-85.
7. Mathur R, Evbuomwan I, Jenkins J. Prevention and management of ovarian hyperstimulation syndrome. Current Obstet Gynaecol 2005; 15: 132-138.
8. Royal College of Obstetricians and Gynaecologists (RCOG). The management of ovarian hyperstimulation syndrome. RCOG green-top guideline number 5. RCOG Press: London, 2006; 1-11.
9. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992; 58: 249-261.
10. Sladkevicius P, Valentin L, Marsal K. Blood flow velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound Obstet Gynecol 1993; 3: 199-208.
11. Zaidi J, Barber J, Kyei-Mensah A, Bekir J, Campbell S, Tan SL. Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 1996; 88: 779-784.
12. Kupesic S, Kurjak A. Predictors of IVF outcome by threedimensional ultrasound. Hum Reprod 2002; 17: 950-955.
13. Mercé LT, Barco MJ, Bau S, Troyano JM. Prediction of ovarian response and IVF/ICSI outcome by three-dimensional ultrasonography and power Doppler angiography. Eur J Obstet Gynecol Reprod Biol 2007; 132: 93-100.
14. Ng EH, Tang OS, Chan CC, Ho PC. Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment. Hum Reprod 2005; 20: 3147-3151.
15. Ng EH, Tang OS, Chan CC, Ho PC. Ovarian stromal vascularity is not predictive of ovarian response and pregnancy. Reprod Biomed Online 2006; 12: 43-49.
16. Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S, Jacobs H. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 1998; 70: 651-658.
17. Zaidi J, Collins W, Campbell S, Pittrof R, Tan SL. Blood flow changes in the intraovarian arteries during the periovulatory period: relationship to the time of day. Ultrasound Obstet Gynecol 1996; 7: 135-140.
18. Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, Tan SL, Campbell S, Jacobs HS. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 1998; 13: 651-655.
19. Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR, Johnson IR. The interobserver reliability of three-dimensional power Doppler data acquisition within the female pelvis. Ultrasound Obstet Gynecol 2004; 23: 501-508.
20. Pan HA, Wu MH, Cheng YC, Wu LH, Chang FM. Quantification of ovarian Doppler signal in hyperresponders during in vitro fertilization treatment using three-dimensional power Doppler ultrasonography. Ultrasound Med Biol 2003; 29: 921-927.
21. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002; 77: 328-336.
22. Pan HA, Wu MH, Cheng YC, Wu LH, Chang FM. Quantification of ovarian stromal Doppler signals in poor responders undergoing in vitro fertilization with three-dimensional power Doppler ultrasonography. Am J Obstet Gynecol 2004; 190: 338-344.
23. Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR, Johnson IR. The reliability of virtual organ computer-aided analysis (VOCAL) for the semiquantification of ovarian, endometrial and subendometrial perfusion. Ultrasound Obstet Gynecol 2003; 22: 633-639.
24. Raine-Fenning NJ, Campbell BC, Johnson IR. The semiquantification of three-dimensional power Doppler angiography of the endometrium: preliminary experience. Abstracts from the 33rd British Medical Ultrasound Society Annual Scientific Meeting, Edinburgh, UK, December 2001. Eur J Ultrasound 2002; 15(Suppl. 1): S32.
25. Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR. Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 2008; 32: 551-559.
26. Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, Raine-Fenning NJ. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod 2007; 22: 1932-1941.
27. Raine-Fenning NJ, Campbell BK, Clewes JS, Johnson IR. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003; 29: 1685-1690.
28. Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS, Johnson IR. Quantifying the changes in endometrial vascularity throughout the normal menstrual cycle with three-dimensional power Doppler angiography. Hum Reprod 2004; 19: 330-338.
29. Lam PM, Johnson IR, Raine-Fenning NJ. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod 2007; 22: 3116-3123.
30. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003; 9: 505-514.
31. Zaidi J, Campbell S, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum Reprod 1995; 10: 1992-1996.
32. Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR. Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol 2008; 32: 540-550.
33. MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 597-600.
34. Delvigne A, Demoulin A, Smitz J, Donnez J, Koninckx P, Dhont M, Englert Y, Delbeke L, Darcis L, Gordts S, Puttemans P, Gerris J, Schoysman R, Leroy F. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod 1993; 8: 1353-1360.
35. Hay MF, Moor RM, Cran DG, Dott HM. Regeneration of atretic sheep ovarian follicles in vitro. J Reprod Fertil 1979; 55: 195-207.
36. Moor RM, Seamark RF. Cell signaling, permeability, and microvasculatory changes during antral follicle development in mammals. J Dairy Sci 1986; 69: 927-943.
37. Kwee JJ, Elting MM, Schats RR, McDonnell JJ, Lambalk NC. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol 2007; 5: 9.
38. Ng EH, Tang OS, Ho PC. The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Hum Reprod 2000; 15: 1937-1942.
39. Danninger B, Brunner M, Obruca A, Feichtinger W. Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation. Hum Reprod 1996; 11: 1597-1599.
40. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988; 159: 210-215.